Unique ID issued by UMIN | UMIN000021801 |
---|---|
Receipt number | R000019482 |
Scientific Title | Study on efficacy and safety of Hochuekkito for the treatment of partial paralysis as a complication of cerebrovascular disorder |
Date of disclosure of the study information | 2016/04/06 |
Last modified on | 2017/04/21 12:35:58 |
Study on efficacy and safety of Hochuekkito for the treatment of partial paralysis as a complication of cerebrovascular disorder
Efficacy of Hochuekkito for "partial paralysis" in patients undergoing rehabilitation
Study on efficacy and safety of Hochuekkito for the treatment of partial paralysis as a complication of cerebrovascular disorder
Efficacy of Hochuekkito for "partial paralysis" in patients undergoing rehabilitation
Japan |
Patients undergoing rehabilitation for partial paralysis as a complication of cerebrovascular disorder
Rehabilitation medicine |
Others
NO
To explore the efficacy of Hochuekkito tor decreased ADL due to partial paralysis in patients undergoing rehabilitation after cerebrovascular disorder, and to collect and evaluate safety information.
Safety,Efficacy
Exploratory
Pragmatic
Phase II
FIM(Functional Independence Measure)
Alb,Body weight,BMI,%Ideal body weight,Lymphocyte number,Hb,CRP,Incidence rate of complication
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Active
NO
YES
Central registration
2
Treatment
Medicine |
TSUMURA Hochuekkito Extract Granules for Ethical Use
control
50 | years-old | <= |
80 | years-old | > |
Male and Female
1)Patients with partial paralysis as a complication of cerebrovascular disorder
2)Patients with Functional Independence Measur(FIM;foe ADL evaluation) score of 40 points or lower
3)Recovering patients who have started rehabilitation within 1 week
4)Patients with Alb of less than 3.5g/dL
5)Patients aged 50 years or older and younger than 80 years (when giving informed consent)
6)Patients who can take oral investigational drugs
7)Both males and females are eligible
8)Inpatients
9)Patients who are able to give written informed consent
Patients who have any of the following conditions:
1)Insufficient nutrition intake (less than 1,400kcal/day)
2)CRP of 10g/dL or more
3)Grade 2 or severer on the physical disability certificate or Grade 3 or severer certification of long-term care need since before the onset of cerebrovascular disorder
4)Use of any Kampo medicine within 4 weeks before study initiation
5)Serious comorbidities (e.g., hepatic, renal, cardiac, hematological, and metabolic diseases)
6)Any other condition assessed as inappropriate for study participation by the investigator or subinvestigator (hereinafter referred to as "investigators, etc.")
100
1st name | |
Middle name | |
Last name | Naoki Fukumura |
Tsuruoka Kyoritu Rehabilitation Hospital
Department of Rehabilitation
38 Simmeimae, Kamiyamazoe, Tsuruoka City, Japan
0235-78-7511
fukumuranaoki@gmail.com
1st name | |
Middle name | |
Last name | Naoki Fukumura |
Tsuruoka Kyoritu Rehabilitation Hospital
Department of Rehabilitation
38 Simmeimae, Kamiyamazoe, Tsuruoka City, Japan
0235-78-7511
fukumuranaoki@gmail.com
Department of Rehabilitation
Tsuruoka Kyoritu Rehabilitation Hospital
TSUMURA & Co.
Profit organization
Japan
NO
鶴岡協立リハビリテーション病院(山形県)
2016 | Year | 04 | Month | 06 | Day |
Published
Main results already published
2013 | Year | 04 | Month | 01 | Day |
2013 | Year | 04 | Month | 01 | Day |
2015 | Year | 03 | Month | 31 | Day |
2016 | Year | 08 | Month | 31 | Day |
2016 | Year | 08 | Month | 31 | Day |
2016 | Year | 08 | Month | 31 | Day |
2016 | Year | 04 | Month | 06 | Day |
2017 | Year | 04 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019482
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |